00905nas a2200181 4500000000100000008004100001260001300042653001100055653001300066100001600079700001700095700001600112245001400128300001800142490000700160520054200167022001400709 2005 d c2005 Dec10aHumans10aVitiligo1 aHuggins R H1 aSchwartz R A1 aJanniger KC00aVitiligo. a137-42, 144-50 v143 a

Vitiligo represents a selective destruction of the melanocytes. It is a relatively common, probably autoimmune disorder that affects people of all backgrounds and both genders. No particular group seems to be preferentially affected. Half of vitiligo patients have an onset before the age of 18 years. In regions where leprosy is endemic, individuals with vitiligo are often stigmatized due to similarities in appearance between the two diseases. We will review this important subject, emphasizing the latest therapeutic advances.

 a1318-4458